HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dabigatran-associated Acute Generalized Exanthematous Pustulosis (AGEP) in a psoriatic patient undergoing Ixekizumab and its pathogenetic mechanism.

AuthorsKory Schrom, Alessia Pacifico, Ruzica R Z Conic, Paolo D M Pigatto, Piergiorgio Malagoli, Aldo Morrone, Renata Finelli, Nicola L Bragazzi, Giovanni Damiani
JournalDermatologic therapy (Dermatol Ther) Vol. 32 Issue 5 Pg. e13018 (09 2019) ISSN: 1529-8019 [Electronic] United States
PMID31286621 (Publication Type: Case Reports, Letter, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antithrombins
  • Dermatologic Agents
  • Interleukin-17
  • ixekizumab
  • Dabigatran
Topics
  • Acute Generalized Exanthematous Pustulosis (diagnosis, etiology)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Antithrombins (adverse effects, therapeutic use)
  • Atrial Fibrillation (complications, drug therapy)
  • Dabigatran (adverse effects, therapeutic use)
  • Dermatologic Agents (therapeutic use)
  • Humans
  • Interleukin-17
  • Male
  • Middle Aged
  • Psoriasis (complications, diagnosis, drug therapy)
  • Skin (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: